FDA
approval
· 2016-03-30
FDA Approved: DEFITELIO — Original Application (Jazz Pharmaceuticals, Inc.)
Summary
The FDA approved Defibrotide (Defitelio) as the original application for the treatment of hepatic veno-occlusive disease in adults and children after hematopoie…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for DEFITELIO (DEFIBROTIDE SODIUM)